Healthcare provider profile · identity verified

Yitzchok Barry Kurtzer, MD

Allopathic & Osteopathic Physicians|Internal Medicine · SCRANTON, PA · NPI 1154321891

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Yitzchok Barry Kurtzer, MD received $54.84 in general payments during 2025 across 3 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 42.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Brilinta by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 107 claims for Farxiga by this doctor in 2024.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 86 claims for Jardiance by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 65 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$54.84

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$23.25	42.4%	1	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$16.32	29.8%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$15.27	27.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$54.84	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$23.25	1	2025
Source payment records 2025-01-16 · Boehringer Ingelheim Pharmaceuticals, Inc. · $23.25 · Open Payments source
BREZTRI Normalized: breztri	Drug	AstraZeneca Pharmaceuticals LP	$16.32	1	2025
Source payment records 2025-01-15 · AstraZeneca Pharmaceuticals LP · $16.32 · Open Payments source
Wegovy Normalized: wegovy	Drug	Novo Nordisk Inc	$15.27	1	2025
Source payment records 2025-01-13 · Novo Nordisk Inc · $15.27 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	86	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BRILINTA open payments reported associated product	CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430	Brilinta · 2024 Exact normalized brand match · 1 Part D row	13	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	107	26
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	86	21
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	65	21
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	26	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	646	176
Gabapentin	Gabapentin	635	123
Amlodipine Besylate	Amlodipine Besylate	524	135
Levothyroxine Sodium	Levothyroxine Sodium	450	103
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	403	71
Pantoprazole Sodium	Pantoprazole Sodium	354	93
Omeprazole	Omeprazole	338	66
Alprazolam	Alprazolam	331	70
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	329	47
Furosemide	Furosemide	320	81
Metoprolol Succinate	Metoprolol Succinate	307	73
Meloxicam	Meloxicam	298	75
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	297	87
Montelukast Sodium	Montelukast Sodium	297	90
Losartan Potassium	Losartan Potassium	282	80
Lisinopril	Lisinopril	257	69
Zolpidem Tartrate	Zolpidem Tartrate	239	55
Oxycodone Hcl	Oxycodone Hcl	236	27
Metformin Hcl	Metformin Hcl	213	63
Metoprolol Tartrate	Metoprolol Tartrate	207	57
Tamsulosin Hcl	Tamsulosin Hcl	197	58
Eliquis	Apixaban	191	38
Simvastatin	Simvastatin	180	44
Albuterol Sulfate Hfa	Albuterol Sulfate	178	62
Prednisone	Prednisone	169	82
Methylprednisolone	Methylprednisolone	168	121
Azithromycin	Azithromycin	165	113
Levofloxacin	Levofloxacin	162	103
Citalopram Hbr	Citalopram Hydrobromide	155	34
Duloxetine Hcl	Duloxetine Hcl	155	29
Rosuvastatin Calcium	Rosuvastatin Calcium	148	46
Trazodone Hcl	Trazodone Hcl	145	35
Hydrochlorothiazide	Hydrochlorothiazide	140	36
Clopidogrel	Clopidogrel Bisulfate	135	36
Tramadol Hcl	Tramadol Hcl	133	43
Clonazepam	Clonazepam	131	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	126	39
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	116	31
Ibuprofen	Ibuprofen	109	29
Farxiga	Dapagliflozin Propanediol	107	26
Meclizine Hcl	Meclizine Hcl	107	43
Allopurinol	Allopurinol	99	28
Fluticasone Propionate	Fluticasone Propionate	99	37
Torsemide	Torsemide	99	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	97	71
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	95	14
Ondansetron Hcl	Ondansetron Hcl	92	26
Mupirocin	Mupirocin	88	45
Jardiance	Empagliflozin	86	21
Donepezil Hcl	Donepezil Hcl	83	21
Glimepiride	Glimepiride	79	19
Amitriptyline Hcl	Amitriptyline Hcl	74	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	72	59
Potassium Chloride	Potassium Chloride	72	15
Mounjaro	Tirzepatide	70	14
Ozempic	Semaglutide	65	21
Fenofibrate	Fenofibrate Nanocrystallized	64	14
Glipizide	Glipizide	64	19
Spironolactone	Spironolactone	64	17
Nystatin	Nystatin	62	28
Ropinirole Hcl	Ropinirole Hcl	61	12
Xarelto	Rivaroxaban	61	12
Nebivolol Hcl	Nebivolol Hcl	60	14
Warfarin Sodium	Warfarin Sodium	60	suppressed
Buspirone Hcl	Buspirone Hcl	59	11
Januvia	Sitagliptin Phosphate	58	15
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	57	24
Methylphenidate Hcl	Methylphenidate Hcl	57	suppressed
Myrbetriq	Mirabegron	57	13
Carvedilol	Carvedilol	56	15
Cefdinir	Cefdinir	55	42
Linzess	Linaclotide	55	suppressed
Sertraline Hcl	Sertraline Hcl	55	18
Vitamin D2	Ergocalciferol (Vitamin D2)	55	15
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	54	16
Diclofenac Sodium	Diclofenac Sodium	53	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	16
Pregabalin	Pregabalin	52	11
Hydroxyzine Hcl	Hydroxyzine Hcl	51	12
Levetiracetam	Levetiracetam	51	suppressed
Ezetimibe	Ezetimibe	50	17
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	49	suppressed
Atenolol	Atenolol	48	18
Lorazepam	Lorazepam	48	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	suppressed
Clindamycin Hcl	Clindamycin Hcl	44	34
Finasteride	Finasteride	44	12
Ondansetron Odt	Ondansetron	44	19
Synthroid	Levothyroxine Sodium	44	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	13
Mirtazapine	Mirtazapine	43	12
Betamethasone Dipropionate	Betamethasone Dipropionate	42	18
Valacyclovir	Valacyclovir Hcl	42	11
Amoxicillin	Amoxicillin	41	28
Diazepam	Diazepam	39	11
Doxycycline Hyclate	Doxycycline Hyclate	39	34
Famotidine	Famotidine	39	13
Tizanidine Hcl	Tizanidine Hcl	39	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	37	16
Fluconazole	Fluconazole	37	14
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Trintellix	Vortioxetine Hydrobromide	37	suppressed
Terbinafine Hcl	Terbinafine Hcl	36	24
Escitalopram Oxalate	Escitalopram Oxalate	35	11
Celecoxib	Celecoxib	34	11
Bupropion Xl	Bupropion Hcl	33	suppressed
Glyxambi	Empagliflozin/Linagliptin	33	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	33	22
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	26
Triamcinolone Acetonide	Triamcinolone Acetonide	33	15
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	32	20
Trijardy Xr	Empaglifloz/Linaglip/Metformin	32	suppressed
Clonidine Hcl	Clonidine Hcl	30	11
Memantine Hcl	Memantine Hcl	30	suppressed
Bupropion Hcl	Bupropion Hcl	28	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Cephalexin	Cephalexin	27	16
Risperidone	Risperidone	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Dexlansoprazole Dr	Dexlansoprazole	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Loperamide	Loperamide Hcl	26	11
Rybelsus	Semaglutide	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Temazepam	Temazepam	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Kerendia	Finerenone	25	suppressed
Topiramate	Topiramate	25	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Eszopiclone	Eszopiclone	22	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	21	suppressed
Repatha Sureclick	Evolocumab	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Invokana	Canagliflozin	20	suppressed
Baclofen	Baclofen	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Oxcarbazepine	Oxcarbazepine	19	suppressed
Phenobarbital	Phenobarbital	19	suppressed
Vilazodone Hcl	Vilazodone Hcl	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Androgel	Testosterone	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Edarbyclor	Azilsartan Med/Chlorthalidone	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Ramipril	Ramipril	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Belsomra	Suvorexant	14	suppressed
Nexletol	Bempedoic Acid	14	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Vraylar	Cariprazine Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Betamethasone Valerate	Betamethasone Valerate	12	suppressed
Colchicine	Colchicine	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Rexulti	Brexpiprazole	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Vancomycin Hcl	Vancomycin Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Metronidazole	Metronidazole	11	11
Nifedipine Er	Nifedipine	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$54.84 · 3 records	Boehringer Ingelheim Pharmaceuticals, Inc.	BREZTRI, JARDIANCE, Wegovy	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error